GENEWIZ Gene Synthesis from Azenta Life Sciences is known for the reliability and completion of projects with a wide range of complexity levels including repetitive, and sequences with high or low GC content. Our 99.9% delivery rate makes us the partner of choice for top research institutions across the world. Our many years of synthetic gene assembly experience provide endless opportunities to create any custom sequence for your synthetic biology research. Try our gene synthesis services today.
Institutions
Citations
Top pharmaceutical companies
Nobel laureate labs
Standard Deliverables | |
DNA | 2-5ug of plasmid DNA: -Synthetic insert verified by Sanger sequencing -Lyophilized or dissolved in TE buffer |
Documentation |
Certificate of Analysis (COA) file: -Sample information -Restriction digest gel image -Sequencing alignment and trace files -Sequence files of synthetic insert and insert in custom vector (if applicable) |
Storage | Free onboarding and storage of submitted samples and final constructs for up to two years for use in future projects |
Optional add-on services include large-scale DNA preps (ranging from midi- to giga-scale), normalization, custom restriction enzyme digestion, low-endotoxin DNA preps, delivery in specialized tubes or well-plates, linearization, and circularization.
Maximize protein expression and experimental performance with our proprietary bioinformatics platform and >99.8% project success rate
Free vector onboarding with no additional project time; scale your synthesis from microgram up to multi-gram preps
100% Sanger sequencing accuracy and restriction digest of product ensures you receive the genes you requested
Free storage of vectors and plasmids for 2 years with real-time customer and order support across 10+ time zones
As a member of the International Gene Synthesis Consortium (IGSC), we follow its Harmonized Screening Protocol to prevent the misuse of synthetic genes. This protocol thoroughly screens ordered gene sequences to identify any "sequences of concern" (SOCs) and the customers submitting those orders. If a SOC is detected, we will conduct further evaluation to assess potential risks before proceeding.
To ensure compliance with U.S. regulations, we also implement strict biosecurity and export control measures following the Framework for Nucleic Acid Synthesis Screening issued by the White House Office of Science and Technology Policy (OSTP) on April 29, 2024.
We will promptly update this statement if any changes to compliance requirements or the screening framework occur.
• >99.9% synthetic order accuracy
• >82% of projects delivered before the quoted delivery date
• >99.8% project success rate
• Real-time response across 10+ time zones
• >70 Ph.D.-level customer support scientists
• Local multilingual support
• 2,600+ sample pickup/drop off locations worldwide
• 100% sequence verification included with every clonal construct
• Free vector onboarding and storage of deliverables for 2 years
Codon preference is among the most critical parameters affecting the expression level of foreign genes. This tech note will discuss two practical case studies, comparing wild-type gene performance to our codon-optimized sequences.
Building and manipulating large DNA molecules pose several complications that are problematic for de novo synthesis and sequence verification. In this application note, we discuss how our established difficult template protocols enable accurate construction of even the most challenging regions
Recombinant antibody production is a cornerstone of modern biotechnology and research, but it faces the significant challenge of achieving high yields. In this application note, discover how to enhance expression efficiency while reducing production times with an optimized vector backbone workflow.